GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pro-Dex Inc (NAS:PDEX) » Definitions » Cyclically Adjusted Price-to-FCF

Pro-Dex (Pro-Dex) Cyclically Adjusted Price-to-FCF : 116.12 (As of May. 27, 2024)


View and export this data going back to 1986. Start your Free Trial

What is Pro-Dex Cyclically Adjusted Price-to-FCF?

As of today (2024-05-27), Pro-Dex's current share price is $19.74. Pro-Dex's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was $0.17. Pro-Dex's Cyclically Adjusted Price-to-FCF for today is 116.12.

The historical rank and industry rank for Pro-Dex's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

PDEX' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 8.64   Med: 39.07   Max: 2513
Current: 115.45

During the past years, Pro-Dex's highest Cyclically Adjusted Price-to-FCF was 2513.00. The lowest was 8.64. And the median was 39.07.

PDEX's Cyclically Adjusted Price-to-FCF is ranked worse than
86.96% of 230 companies
in the Medical Devices & Instruments industry
Industry Median: 44.1 vs PDEX: 115.45

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Pro-Dex's adjusted free cash flow per share data for the three months ended in Mar. 2024 was $1.124. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $0.17 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Pro-Dex Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Pro-Dex's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pro-Dex Cyclically Adjusted Price-to-FCF Chart

Pro-Dex Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.81 66.81 - - 612.97

Pro-Dex Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 942.57 612.97 262.97 256.47 102.93

Competitive Comparison of Pro-Dex's Cyclically Adjusted Price-to-FCF

For the Medical Instruments & Supplies subindustry, Pro-Dex's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pro-Dex's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pro-Dex's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Pro-Dex's Cyclically Adjusted Price-to-FCF falls into.



Pro-Dex Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Pro-Dex's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=19.74/0.17
=116.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pro-Dex's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Pro-Dex's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.124/131.7762*131.7762
=1.124

Current CPI (Mar. 2024) = 131.7762.

Pro-Dex Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.016 100.560 -0.021
201409 0.104 100.428 0.136
201412 -0.107 99.070 -0.142
201503 -0.174 99.621 -0.230
201506 -0.085 100.684 -0.111
201509 -0.155 100.392 -0.203
201512 0.070 99.792 0.092
201603 -0.190 100.470 -0.249
201606 0.305 101.688 0.395
201609 -0.018 101.861 -0.023
201612 0.107 101.863 0.138
201703 0.243 102.862 0.311
201706 0.308 103.349 0.393
201709 0.218 104.136 0.276
201712 -0.077 104.011 -0.098
201803 0.087 105.290 0.109
201806 0.274 106.317 0.340
201809 0.036 106.507 0.045
201812 0.187 105.998 0.232
201903 0.252 107.251 0.310
201906 -0.023 108.070 -0.028
201909 0.205 108.329 0.249
201912 0.339 108.420 0.412
202003 -0.090 108.902 -0.109
202006 0.616 108.767 0.746
202009 -0.246 109.815 -0.295
202012 -1.185 109.897 -1.421
202103 -1.123 111.754 -1.324
202106 -0.053 114.631 -0.061
202109 0.487 115.734 0.555
202112 0.340 117.630 0.381
202203 0.002 121.301 0.002
202206 -1.514 125.017 -1.596
202209 0.735 125.227 0.773
202212 -0.248 125.222 -0.261
202303 0.608 127.348 0.629
202306 0.133 128.729 0.136
202309 0.075 129.860 0.076
202312 0.021 129.419 0.021
202403 1.124 131.776 1.124

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Pro-Dex  (NAS:PDEX) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Pro-Dex Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Pro-Dex's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Pro-Dex (Pro-Dex) Business Description

Traded in Other Exchanges
Address
2361 McGaw Avenue, Irvine, CA, USA, 92614
Pro-Dex Inc is engaged in designing, developing, and manufacturing powered rotary drive surgical and dental instruments used primarily in the orthopedic, spine, maxocranial facial and dental markets. The company also designs and manufactures multi-axis motion control systems used in factory automation and scientific research markets. In addition, the company provides engineering consulting and placement services, as well as quality and regulatory consulting services. Most of the company's revenue is derived from designing, developing, and manufacturing surgical devices for the medical device and dental industries.
Executives
Angelita Rebamontan Domingo director 1431 MADISON ST., TUSTIN CA 92782
Van Kirk Richard Lee Jr director, officer: Chief Executive Officer 34 DEER CREEK, IRVINE CA 92604
Philp Katrina Marie Kramer director 5501 NANTUCKET PL, MINNETONKA MN 55345
Farrell William James Iii director 20200 COTTAGEWOOD RD, DEEPHAVEN MN 55331
Peter O. Haeg 10 percent owner 12701 WHITEWATER DR, SUITE 190, MINNETONKA MN 55343
Alisha Charlton officer: Chief Financial Officer 25541 COMMERCENTRE DRIVE, LAKE FOREST CA 92630
Nicholas John Swenson 10 percent owner 5000 WEST 36TH STREET, SUITE 130, MINNEAPOLIS MN 55416
Raymond E Cabillot director 3033 EXCELSIOR BLVD., STE 560, MINNEAPOLIS MN 55416
David Hovda director
Farnam Street Partners Lp /mn 10 percent owner 3033 EXCELSIOR BOULEVARD, MINNEAPOLIS, MINNEAPOLIS MN 55416
Ao Partners I, Lp 10 percent owner 5000 WEST 36TH STREET, SUITE 130, MINNEAPOLIS MN 55416
David Holder director 1052 CHARWOOD LANE, SANTA ANA CA 92705
William L Healey director 101 BULLITT LANE, STE 450, LOUISVILLE KY 40222
Michael J Berthelot director P O BOX 7277, RANCHO SANTA FE CA 92067
George J Isaac director 36 WHISPER DRIVE, WORCESTER MA 01609